Companies / BOC Sciences / Aducanumab
BOC Sciences

Aducanumab | BOC Sciences

Aducanumab is a human monoclonal antibody targeting amyloid-_ (A_). Aducanumab has been approved for the treatment of Alzheimer's disease (AD).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.